Monografie
Role of Stem Cell Factor in the Development of Alzheimer's Disease
- Sprache
-
Englisch
- Identifier
-
1160600651
Thema
Alzheimer's disease; Dementia; Amyloid; Biochemical markers; Brain; Alzheimer-Krankheit ; Demenz ; Stammzellenfaktor
Beteiligte Personen und Organisationen
Sopova, Kateryna
Laske, Christoph
Laske, Christoph
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:52 MEZ
Objekttyp
- Monografie
Beteiligte
- Sopova, Kateryna
- Laske, Christoph
Ähnliche Objekte (12)
Characterization of circulating microRNAs as potential biomarkers for dementia
Discrimination between CMV infection and Alzheimer's disease as driving forces for immune senescence
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial phagocytosis of amyloid plaques in an ex vivo model of Alzheimer's Disease
Characterization of proteins involved in the production of β-Amyloid peptides and tau hyperphosphorlation in Familial Alzheimer’s Disease
Dealing with wandering in dementia care : a developmental story of designing a GPS monitoring system and its challenges in a wider context
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
![Diagnostischer Wert der Liquorbiomarker Aβ42 [A-Beta-42], Gesamt-Tau-Protein und Phospho-Tau für die Alzheimer-Demenz in der klinischen Routinediagnostik](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Diagnostischer Wert der Liquorbiomarker Aβ42 [A-Beta-42], Gesamt-Tau-Protein und Phospho-Tau für die Alzheimer-Demenz in der klinischen Routinediagnostik
Aβ-Peptid- [A-beta-Peptid-] und Tau-Phosphorylierungsmuster im Zusammenhang mit der Verteilung und Aktivierung der extrazellulär regulierten Proteinkinase ERK 1/2 in post mortem Hirngewebe von Alzheimer-Patienten
Einfluss proinflammatorischer Zytokine auf die Aβ-Sekretion [A-Beta-Sekretion] mononukleärer Phagozyten
Characterization of circulating microRNAs as potential biomarkers for dementia
Discrimination between CMV infection and Alzheimer's disease as driving forces for immune senescence
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial phagocytosis of amyloid plaques in an ex vivo model of Alzheimer's Disease
Characterization of proteins involved in the production of β-Amyloid peptides and tau hyperphosphorlation in Familial Alzheimer’s Disease
Dealing with wandering in dementia care : a developmental story of designing a GPS monitoring system and its challenges in a wider context
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
Diagnostischer Wert der Liquorbiomarker Aβ42 [A-Beta-42], Gesamt-Tau-Protein und Phospho-Tau für die Alzheimer-Demenz in der klinischen Routinediagnostik
Aβ-Peptid- [A-beta-Peptid-] und Tau-Phosphorylierungsmuster im Zusammenhang mit der Verteilung und Aktivierung der extrazellulär regulierten Proteinkinase ERK 1/2 in post mortem Hirngewebe von Alzheimer-Patienten
Einfluss proinflammatorischer Zytokine auf die Aβ-Sekretion [A-Beta-Sekretion] mononukleärer Phagozyten
Characterization of circulating microRNAs as potential biomarkers for dementia
Discrimination between CMV infection and Alzheimer's disease as driving forces for immune senescence
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Microglial phagocytosis of amyloid plaques in an ex vivo model of Alzheimer's Disease
Characterization of proteins involved in the production of β-Amyloid peptides and tau hyperphosphorlation in Familial Alzheimer’s Disease
Dealing with wandering in dementia care : a developmental story of designing a GPS monitoring system and its challenges in a wider context
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
Diagnostischer Wert der Liquorbiomarker Aβ42 [A-Beta-42], Gesamt-Tau-Protein und Phospho-Tau für die Alzheimer-Demenz in der klinischen Routinediagnostik
Aβ-Peptid- [A-beta-Peptid-] und Tau-Phosphorylierungsmuster im Zusammenhang mit der Verteilung und Aktivierung der extrazellulär regulierten Proteinkinase ERK 1/2 in post mortem Hirngewebe von Alzheimer-Patienten